Document is current

Article History

Received: 17 September 2024

Accepted: 17 November 2024

First Online: 7 December 2024

Declarations

:

: Richard A. Feelders reports a relationship with Recordati Rare Diseases and with Corcept Therapeutics Inc that includes consulting or advisory and funding grants. The other authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

: This study was conducted in accordance with the principles outlined in the Declaration of Helsinki (as revised in 2013). The study was approved by the local medical-ethical committee of the Erasmus Medical Center Rotterdam (MEC-2020-0445 and MEC-2018-1512).

: The requirement for formal written consent was waived due to the retrospective design of the study, which relied solely on routinely collected clinical data. Patients had the opportunity to object to the use of their data in accordance with institutional policies.

: All procedures were approved by the local medical-ethical committee of the Erasmus Medical Center Rotterdam (MEC-2020-0445 and MEC-2018-1512).